首页> 外文OA文献 >Long‑term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD‑L1 expression

【2h】

Long‑term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD‑L1 expression

机译：在具有中间肿瘤突变负荷和PD-L1表达的中间肿瘤突变负荷和阴性的肛肠黑素瘤的情况下对IPILIMIMAB失败的长期反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hitomi Sakai; Masayuki Takeda; Kazuko Sakai; Kazuto Nishio; Kazuhiko Nakagawa;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of Cabozantinib and Nivolumab in Treating Hepatocellular Carcinoma with RET RET Amplification, High Tumor Mutational Burden, and PD‐L1 Expression [J] . Yang Xiaobo, Shi Junping, Chen Xiaoqian, The oncologist . 2020,第6期

机译：Cabozantib和Nivolumab在治疗肝细胞癌治疗肝癌的疗效，高肿瘤突变负担和PD-L1表达
2. Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer [J] . Barroso-Sousa Romualdo, Keenan Tanya E., Pernas Sonia, Clinical cancer research: an official journal of the American Association for Cancer Research . 2020,第11期

机译：肿瘤突变负担和PTEN改变作为对PD-1 / L1阻断在转移性三重阴性乳腺癌中的反应的相关性
3. A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages [J] . Hiromi Watanabe, Kadoaki Ohashi, Kazuya Nishii, Internal medicine. . 2019,第20期

机译：PD-L1阴性肺腺癌伴EGFR突变和周围的PD-L1阳性肿瘤相关巨噬细胞对Nivolumab的长期反应
4. Histopathological and Expression Profiling Studies of early Tumor Responses to Near-Infrared PDT Treatment in SCID Mice [C] . Jean R. Starkey, Aleksander Rebane, Mikhail A. Drobizhev, Conference on Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy; 20080119-20; San Jose,CA(US) . 2008

机译：SCID小鼠对近红外PDT治疗的早期肿瘤反应的组织病理学和表达谱研究
5. Long-term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD-L1 expression [O] . Hitomi Sakai, Masayuki Takeda, Kazuko Sakai, -1

机译：患有中等肿瘤突变负担且PD-L1表达阴性的肛门直肠黑色素瘤患者nivolumab失败后对ipilimumab的长期反应
6. Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer [O] . Romualdo Barroso-Sousa, Tanya E. Keenan, Sonia Pernas, 2020

机译：肿瘤突变负担和PTEN改变作为对PD-1 / L1阻断在转移性三重阴性乳腺癌中的反应的相关性

Long‑term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD‑L1 expression

著录项

引文网络

相似文献

相关主题

期刊订阅